SUMMARY Alkaline phosphatase has been extracted from human pancreas with n-butanol and has been shown to have distinctive isoenzyme characteristics when compared with the enzymes of small intestine and of normal serum. The enzyme has been demonstrated histochemically in a carcinoma of the pancreas and also in an islet cell tumour and the tumour enzyme has been shown to be unique, not only electrophoretically, but in being remarkably heat sensitive and in being activated by low molarities of urea.
Alkaline phosphatase has recently been reported in the duct system, islet cells, and acini of the human pancreas (Warnes and Bulmer, 1970) . The enzyme is known to exist in multiple molecular forms, termed isoenzymes, which differ in biochemical characteristics in such a way that the different organ sources of alkaline phosphatase in serum can be detected by means of differing rates of heat inactivation (Posen, Neale, and Clubb, 1965) and urea inactivation (Bahr and Wilkinson, 1967) and differing reactions with L-phenylalanine (Fishman, Green, and Inglis, 1963) , together with electrophoretic separation on a variety of media (Newton, 1967; Kaplan and Rogers, 1969) . Studies with neuraminidase have shown that alkaline phosphatase isoenzymes may differ in their content of neuraminic acid (Robinson and Pierce, 1964) and that in some tissues this may be one of the bases of their heterogeneity (Butterworth and Moss, 1966; Bachawat, 1969) .
The sources of alkaline phosphatase in human serum include liver, bone, small intestine, and placenta, but recently a wide variety of tumours have been shown to secrete alkaline phosphatase into the blood (Lancet, 1969) . This tumour alkaline phosphatase, termed the 'Regan isoenzyme', is recognizable biochemically since it has properties identical to those of placental alkaline phosphatase both electrophoretically, and in being heat stable and highly sensitive to L-phenylalanine (Fishman, Inglis, Stolbach, and Krant, 1968; Stolbach, Krant, and Fishman, 1969) . Inthispaper the isoenzymecharacteristics of normal pancreatic alkaline phosphatase are described and contrasted with the alkaline phosReceived for publication 19 April 1972. phatase extracted from two pancreatic tumours which has unique properties differing markedly from those of the Regan isoenzyme. Neuraminidase studies show that the difference between normal pancreatic alkaline phosphatase and the tumour isoenzyme is not explained by their differing contents of sialic acid.
Materials and Methods
Fresh pancreas was obtained at operation from patients undergoing total or partial pancreatectomy for chronic pancreatitis or during the course of gastrectomy for gastric carcinoma. From this material portions were obtained which were both macroscopically andmicroscopicallynormal. Tissueextracts of this material, together with a carcinoma of the body of the pancreas obtained at laparotomy, and an insulinoma obtained atfnecropsy, were made by extraction with n-butanol (Morton, 1954) . Cryostat sections were cut from normal pancreas and the two tumours and stained for alkaline phosphatase by the method of Burstone (Burstone, 1958a and b) . Alkaline phosphatase determinations on the tissue extracts were by the Kind-King modification of the King-Armstrong method (Kind and King, 1954) . HEAT INACTIVATION Studies were based on the method of Posen et al (Posen, Neale, and Clubb, 1965) .
UREA INHIBITION
Tests were performed by a modification ofthe method of Bahr and Wilkinson (1967) . 513 PHENYLALANINE INHIBITION This was performed by comparing the enzyme activity of the test solution when 5 mM L-phenylalanine was present in the assay system, with the activity of the same extracts in the presence of D-phenylalanine (Fishman et al, 1963) .
ACRYLAMIDE GEL ELECTROPHORESIS
Samples of the extracts were subjected to 'disc' electrophoresis in a Shandon electrophoresis tank (Shandon Scientific Company Ltd, London), using a 5 % polyacrylamide gel and a continuous buffer system (Smith, Lightstone, and Perry, 1968) . A sample of normal serum was run in parallel for comparison. The enzyme bands were located by staining with f-naphthyl phosphate and Fast Blue BB.
PREINCUBATION WITH NEURAMINIDASE
Before electrophoresis this was carried out by the method of Robinson and Pierce (1964) . Aliquots, each of 0.05 ml, of Vibrio cholerae neuraminidase (Koch-Light) containing 500 units/ml were incubated with 0.05 ml of tissue extract at 37°C for 20 hours before acrylamide gel electrophoresis.
Results

HISTOCHEMISTRY
The cells of the poorly differentiated adenocarcinoma of the pancreas stained strongly for alkaline phosphatase ( Fig. 1) , which was also seen in reactive fibroblasts and capillaries in the tumour. The islet cell tumour showed a weaker reaction (Fig. 2) .
ISOENZYME STUDIES ON NORMAL PANCREAS
There was quite a wide variation in the amount of alkaline phosphatase extracted from the six specimens of 'normal' pancreas, varying from 0.012 to 0 042 KA units/mg protein; biochemically, however, pancreatic phosphatase behaved in a reasonably homogeneous manner. The pancreatic isoenzyme was very much more heat sensitive than the small intestinal enzyme (Fig. 3) . The alkaline phos- phatase of normal serum, which is included for comparison, was rather more heat stable than the pancreatic enzyme. The pancreatic enzyme was also more sensitive to urea inhibition than small intestinal alkaline phosphatase, the difference being most marked with 1 molar urea (Fig. 4) . After incubation with the stereo-specific inhibitor L-phenylalanine, pancreatic alkaline phosphatase was largely unaffected, whereas the intestinal enzyme retained only 21 % of its total activity. Electrophoretically, pancreatic alkaline phosphatase showed a diffuse band running behind the liver band in serum but slightly ahead of the more compact band of small intestine (Fig. 5) blastic bone disease, and it is clear that the pancreatic isoenzyme is electrophoretically quite distinct from bone, liver, and small intestinal alkaline phosphatases. A further important difference was seen after preincubation with neuraminidase; this removes neuraminic acid residues from phosphatases containing this substance and so reduces their electrophoretic mobility. The mobility of pancreatic alkaline phosphatase was reduced by neuraminidase, indicating that this isoenzyme contains neuraminic acid (Fig. 6, experiment 2) ; the mobility of small intestinal alkaline phosphatase is, in contrast, unaffected by neuraminidase (Fig. 6, experiment 1) .
TUMOUR ISOENZYME STUDIES
The phosphatase of the two tumours differed from 3 ISLET CELL TUMOUR Fig. 7 Inhibition studies on the AP isoenzymes of normal pancreas and the tumour variant.
The biochemical characteristics of the two tumours are depicted in the two right-hand columns of each figure. Along the ordinate is again shown the percentage enzyme activity remaining after the respective inhibitions with phenylalanine, heat, and urea. that of normal pancreas in being remarkably heat sensitive and in showing approximately 20% activation by 025 molar urea (Fig. 7) . The percentage inhibition with L-phenylalanine was, however, the same in the two tumours as in normal pancreas. These biochemical differences were associated with electrophoretic differences between the tumour isoenzymes and that of normal pancreas (Fig. 8) . Both tumours showed a main band in an identical position to that ofnormal pancreas but the carcinoma of pancreas showed in addition two well defined, slow running minor bands, whilst in the islet cell tumour there was a minor band running immediately ahead of the main band. However, the electrophoretic mobility of the main bands was reduced by preincubation with neuraminidase in all three cases. It is likely, therefore, that the tumour isoenzyme represents the production of a modified polypeptide rather than a difference in neuraminic acid content.
Discussion
This work shows that pancreatic alkaline phosphatase is an isoenzyme which is quite distinct from small intestinal alkaline phosphatase in that it is virtually unaffected by 0.005 M L-phenylalanine and is very much more heat and urea sensitive. Nichols, Bower, Williams, and Martin (1966) reported an adrenal carcinoma with a raised level of alkaline phosphatase in serum, which fell after removal of the tumour. A variant form of alkaline phosphatase has been found in the serum of patients with rectal and gastric carcinomas which was identical electrophoretically to that extracted from tumour tissue (Klein, 1968) (Timperley, 1968) . following prebreast, uterus, and cervix, as well as reticulum cell sarcoma, Hodgkin's disease, and multiple myeloma . This tumour variant is indistinguishable from placental alkaline phosphatase either electrophoretically or in its marked heat hosphatase is some-stability and its sensitivity to L-phenylalanine, though itive than serum alka-more recently urea inactivation studies have shown ide variations in the a greater urea sensitivity of the Regan isoenzyme the latter, depending when compared with the placental isoenzyme, hatase predominating suggesting that their three-dimensional structure is nd consequently the different (Fishman, 1969) . The tumour variant may alkaline phosphatase be found in the serum of cancer patients who have m are not statistically quantitatively normal values of serum alkaline tic alkaline phospha-phosphatase (Stolbach, 1969) . The tumour variant le electrophoretically we have found in the pancreas is, however, clearly mal serum. Molecular different from the Regan isoenzyme in that it is G200 gave an approx-remarkably heat sensitive and resistant to L-)0 000 for pancreatic phenylalanine; it is in fact the most heat-sensitive d with 140 000 for the isoenzyme of alkaline phosphatase so far reported. Warnes and S. Smith, The finding of a heat-sensitive, phenylalanineiere is a clear differ-resistant tumour isoenzyme of alkaline phosline phosphatase and phatase is in accord with the findings of similarly ase when they are heat-labile and phenylalanine-resistant tumour isohich slows pancreatic enzymes isolated from other tissues (Timperley, io effect on the intes-1968; Timperley and Warnes, 1970) but the activaears that, like kidney tion of tumour alkaline phosphatase by low molarities of urea is, in our experience, unique, though other workers, using a similar technique, have found an activation of liver alkaline phosphatase by low concentrations of urea (Bahr and Wilkinson, 1967) . It is therefore clear that tumours may produce alkaline phosphatase isoenzymes other than Regan isoenzyme. The latter has been postulated to arise as a result of genome derepression, possibly associated with the action of a virus within the tumour cells ; the heat-sensitive tumour variant we describe is, in contrast, in accord with the observation that mutant genes may cause the synthesis of a structurally altered enzyme protein whose stability is reduced, causing it to be more rapidly broken down in vivo (Harris, 1970) .
Genetically determined protein variants have been found to differ by the substitution of amino acids in polypeptide chains (Ingram, 1961) , by the association offundamental units in varying combinations, as in the case of the lactate dehydrogenases (Markert, 1963) or, as in the case of certain alkaline phosphatase isoenzymes, in their content of neuraminic acid (Robinson and Pierce, 1964) ; the latter explanation has been shown to be inapplicable in the case of the variation between the isoenzymes of normal and neoplastic pancreas.
Alkaline phosphatase is secreted into the pancreatic juice of the dog (Nothmann, 1944) and man (Warnes, Hine, and Kay, 1969) , and ligation of the pancreatic ducts in the dog results in a progressive rise in the serum alkaline phosphatase of pancreatic origin (Nothmann, 1944) . Nothmann further suggested that the level of serum alkaline phosphatase might be used as a diagnostic aid in pancreatic diseases, especially in those producing duct occlusion. The serum from our patient with the carcinoma of the pancreas contained an elevated alkaline phosphatase level which was mainly of 'liver' origin; unfortunately, serum from the patient with the insulinoma was not available for study. Though in many cases an elevated serum alkaline phosphatase level in patients with tumours of the pancreas is due either to liver metastases or to obstruction of the common bile duct, there is recent evidence that pancreatic tumours may themselves be the source of elevated levels of alkaline phosphatase in serum (Mann, Rayner, and Gourevitch, 1969; Gjone, Fretheim, Nord6y, Jacobsen, and Elgjo, 1970) . Knowledge of the isoenzyme characteristics of normal pancreatic alkaline phosphatase and the tumour variant should permit early recognition of this tumour isoenzyme in serum and duodenal juice.
